Drug Profile
Research programme: drug discovery - Hanwha Chemical
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Hanwha Chemical
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cardiovascular disorders; Metabolic disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cardiovascular-disorders in South Korea
- 16 Jul 2016 No recent reports of development identified for preclinical development in Metabolic-disorders in South Korea
- 18 Aug 2009 Preclinical trials in Cardiovascular disorders in South Korea (unspecified route)